Why the study?
Anticoagulation options for paroxysmal atrial fibrillation are limited in dialysis patients, posing unique challenges alongside congenital dextrocardia that may be addressed by a one-stop procedure.
This case report highlights the feasibility of a one-stop procedure for managing paroxysmal atrial fibrillation in a complex patient with dextrocardia and contraindications to standard anticoagulation.
Answers are grounded in this paper and cite their sources.
NOAC use in dialysis patients with AF requires caution; case report leaves open optimal strategies in congenital dextrocardia.
We present the case of an elderly woman with congenital dextrocardia who experienced severe palpitations. An electrocardiogram revealed paroxysmal atrial fibrillation, and her medical history unveiled cerebral infarction and renal failure. In the treatment of paroxysmal atrial fibrillation, anticoagulation is a key requirement. Although non-vitamin K antagonist oral anticoagulants are recommended by guidelines, their efficacy is compromised in patients undergoing dialysis due to renal metabolism. In addition, warfarin may cause fluctuations in international normalized ratio, which is not conducive to controlling symptoms of cerebral infarction. To improve the patient's quality of life, we focused on addressing the unique challenges posed by dextrocardia in a one-stop procedure.
No takes yet. Share an insight, caveat, or question.
Chungyun et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: